Vivus, Why the Slide? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus, Why the Slide?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (2911)	8/1/1997 2:12:00 AM
From: Frostman	of 3991

Cacaito, <Report of PGE1-prazosyn trials could be a catalyst for the rocket. There are three combination doses trials ongoing or will be started soon.> Perhaps you are correct,IMHO, many people are concerned when a company has only one or two products (like Xerox in the 60's or today's WD-40 <g>)R&D trials ease the pressure for these folks and give us all the warm feeling that Vivus is going to need a plethora of shelf-space down the road. Maybe the fuds finally got to the VVUS folder, ran the numbers and liked the story. Maybe Tunica is back. Whatever the facts, you and several others who pay close attention are beginning to talk serious activity. Let the games begin. I'm happy with my position in VVUS. Very happy. Good luck to you, Frostman

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next